News

Photo shows Dr. Ron Cohen, founder, former chairman and CEO of Acorda Therapeutics, speaking at the healthcare symposium ...
During the post-covid bull-run, as investors chased themes around sustainability, the engineering conglomerate’s stock grew ...
On April 17, 2025, the U.S. Environmental Protection Agency (EPA) extended the comment period on a draft risk assessment of ...